|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-9-2
|
|
pubmed:abstractText |
Specific immunotherapy (SIT) is a valuable treatment for respiratory allergy, and the use of chemically modified allergens (allergoids) has improved its safety, as testified by several studies. We evaluated the effects of a SIT course with an allergoid extract of Parietaria pollen in a double-blind, placebo-controlled trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0105-4538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
313-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10371089-Adolescent,
pubmed-meshheading:10371089-Adult,
pubmed-meshheading:10371089-Asthma,
pubmed-meshheading:10371089-Conjunctivitis, Allergic,
pubmed-meshheading:10371089-Desensitization, Immunologic,
pubmed-meshheading:10371089-Double-Blind Method,
pubmed-meshheading:10371089-Female,
pubmed-meshheading:10371089-Humans,
pubmed-meshheading:10371089-Male,
pubmed-meshheading:10371089-Middle Aged,
pubmed-meshheading:10371089-Plant Extracts,
pubmed-meshheading:10371089-Pollen,
pubmed-meshheading:10371089-Rhinitis, Allergic, Perennial,
pubmed-meshheading:10371089-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial.
|
|
pubmed:affiliation |
Servizio di Allergologia, Ospedale di Bordighera (IM), Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
